Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathological and clinical impact of neoadjuvant chemoradiotherapy using full-dose gemcitabine and concurrent radiation for resectable pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Tamamoto T, Nomi T, Yamato I, Hokuto D, Yasuda S, Kawaguchi C, Nishiofuku H, Marugami N, Enomonoto Y, Kasai T, Hasegawa M, Kichikawa K, Nakajima Y. Sho M, et al. Among authors: nakajima y. J Hepatobiliary Pancreat Sci. 2013 Feb;20(2):197-205. doi: 10.1007/s00534-012-0532-8. J Hepatobiliary Pancreat Sci. 2013. PMID: 22766692
Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy.
Nagai M, Sho M, Satoi S, Toyokawa H, Akahori T, Yanagimoto H, Yamamoto T, Hirooka S, Yamaki S, Kinoshita S, Nishiwada S, Ikeda N, Kwon AH, Nakajima Y. Nagai M, et al. Among authors: nakajima y. J Hepatobiliary Pancreat Sci. 2014 Mar;21(3):186-92. doi: 10.1002/jhbp.14. Epub 2013 Jun 20. J Hepatobiliary Pancreat Sci. 2014. PMID: 23798362 Clinical Trial.
Potential role of surgical resection for pancreatic cancer in the very elderly.
Kinoshita S, Sho M, Yanagimoto H, Satoi S, Akahori T, Nagai M, Nishiwada S, Yamamoto T, Hirooka S, Yamaki S, Ikeda N, Kwon AH, Nakajima Y. Kinoshita S, et al. Among authors: nakajima y. Pancreatology. 2015 May-Jun;15(3):240-6. doi: 10.1016/j.pan.2015.03.015. Epub 2015 Apr 8. Pancreatology. 2015. PMID: 25888010
Importance of resectability status in neoadjuvant treatment for pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Tamamoto T, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y. Sho M, et al. Among authors: nakajima y. J Hepatobiliary Pancreat Sci. 2015 Jul;22(7):563-70. doi: 10.1002/jhbp.258. Epub 2015 Apr 29. J Hepatobiliary Pancreat Sci. 2015. PMID: 25921623
Optimal indication of neoadjuvant chemoradiotherapy for pancreatic cancer.
Sho M, Akahori T, Tanaka T, Kinoshita S, Nagai M, Nishiwada S, Tamamoto T, Nishiofuku H, Ohbayashi C, Hasegawa M, Kichikawa K, Nakajima Y. Sho M, et al. Among authors: nakajima y. Langenbecks Arch Surg. 2015 May;400(4):477-85. doi: 10.1007/s00423-015-1304-0. Epub 2015 May 1. Langenbecks Arch Surg. 2015. PMID: 25929828
Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.
Satoi S, Sho M, Yanagimoto H, Yamamoto T, Akahori T, Kinoshita S, Nagai M, Hirooka S, Yamaki S, Nishiwada S, Ryota H, Ikeda N, Nakajima Y, Kon M. Satoi S, et al. Among authors: nakajima y. J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):167-73. doi: 10.1002/jhbp.318. Epub 2016 Feb 14. J Hepatobiliary Pancreat Sci. 2016. PMID: 26748629 Clinical Trial.
Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study.
Sho M, Murakami Y, Kawai M, Motoi F, Satoi S, Matsumoto I, Honda G, Uemura K, Yanagimoto H, Kurata M, Akahori T, Kinoshita S, Nagai M, Nishiwada S, Fukumoto T, Unno M, Yamaue H, Nakajima Y. Sho M, et al. Among authors: nakajima y. J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):188-97. doi: 10.1002/jhbp.320. Epub 2016 Feb 19. J Hepatobiliary Pancreat Sci. 2016. PMID: 26763744
3,686 results